Curanex Pharmaceuticals Inc (CURX)

09:20 AM

Curanex Pharmaceuticals Highlights Patient Case Supporting Phyto-N's Potential in Cancer Cachexia Treatment - Quiver Quantitative

09:20 AM

09:17 AM

One cancer patient kept working 2+ years in Curanex Phyto-N case - Stock Titan

09:17 AM

09:03 AM

EXCLUSIVE: Curanex Highlights Case Study Supporting Cachexia Focus In Oncology Strategy - Benzinga

09:03 AM

Apr 05, 2026

Top Curanex Pharmaceuticals (CURX) Competitors 2026 - MarketBeat

Apr 05, 2026

Apr 04, 2026

EXCLUSIVE: Curanex Pipeline Expansion Signals Push Beyond Inflammation, Metabolic Diseases - MSN

Apr 04, 2026

Apr 04, 2026

Curanex Pharmaceuticals Inc (CURX) stock price, news, quote and history - Yahoo Finance UK

Apr 04, 2026

Apr 03, 2026

Curanex Pharmaceuticals Inc (CURX) latest stock news and headlines - Yahoo Finance Singapore

Apr 03, 2026

Apr 03, 2026

Curanex Pharmaceuticals Inc (CURX) Stock Price, News, Quote & History - Yahoo! Finance Canada

Apr 03, 2026

Apr 02, 2026

Curanex adds cancer cachexia to drug development pipeline - Investing.com

Apr 02, 2026

Apr 02, 2026

Curanex Pharmaceuticals Expands Drug Development Pipeline - TradingView

Apr 02, 2026

Apr 02, 2026

Curanex Adds Cancer Cachexia to Core Drug Pipeline - TipRanks

Apr 02, 2026

Apr 02, 2026

Curanex (Nasdaq: CURX) targets cancer cachexia in expanded pipeline - Stock Titan

Apr 02, 2026

Apr 02, 2026

Curanex Expands Its Drug Development Pipeline to Include Cancer Cachexia, Representing a Multi-Billion-Dollar Market Opportunity and Important Step In The Company’s Evolution Into a Broader Therapeutics Development Company - The Manila Times

Apr 02, 2026

Apr 02, 2026

Curanex adds cancer cachexia to drug development pipeline By Investing.com - Investing.com UK

Apr 02, 2026

Apr 02, 2026

No U.S.-approved treatment exists for cancer cachexia. Curanex adds it - Stock Titan

Apr 02, 2026

Mar 31, 2026

Curanex Pharmaceuticals and Phyto-N: Botanical Drug Development for Inflammatory Diseases, COVID-19, Diabetes, NAFLD, and Gout 33 - Minichart

Mar 31, 2026

Mar 31, 2026

Curanex Advances Phyto-N Toward IND Submission in 2026 Annual Report - National Today

Mar 31, 2026

Mar 30, 2026

Curanex Provides Business Update in Connection with 2025 Annual Report as Phyto-N Advances Toward Planned IND Submission - Bitget

Mar 30, 2026

Mar 30, 2026

CURX: IPO proceeds fund R&D for Phyto-N; no revenue, $4.2M net loss, and internal control weaknesses - TradingView

Mar 30, 2026

Mar 30, 2026

Curanex Pharmaceuticals Inc Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Mar 30, 2026

Mar 30, 2026

Curanex Pharmaceuticals (NASDAQ: CURX) outlines multi-disease Phyto-N drug strategy - Stock Titan

Mar 30, 2026

Mar 30, 2026

Curanex Pharmaceuticals Advances Key Milestones in Manufacturing, Toxicology, and Regulatory Strategy for Phyto-N Development - Quiver Quantitative

Mar 30, 2026

Mar 30, 2026

Ulcerative colitis drug candidate stays on track for late-2026 filing - Stock Titan

Mar 30, 2026

Mar 30, 2026

CURX Ownership | CURANEX PHARMACEUTICALS INC (NASDAQ:CURX) - ChartMill

Mar 30, 2026

Mar 26, 2026

What's Behind Curanex Pharmaceuticals (CURX) 56% Surge After Hours - MSN

Mar 26, 2026

Mar 26, 2026

Stock List: Research Stocks from Around the World - GuruFocus

Mar 26, 2026

Mar 23, 2026

CURANEX PHARMACEUTICALS INC (CURX) Fundamental Analysis & Valuation - chartmill.com

Mar 23, 2026

Mar 20, 2026

CURX Should I Buy - Intellectia AI

Mar 20, 2026

Mar 18, 2026

Nasdaq tumbles over 350 points; US initial jobless claims increase - MSN

Mar 18, 2026

Mar 18, 2026

Curanex Pharmaceuticals IncTargets Ind Submission For Phyto-N In Q4 2026 - TradingView

Mar 18, 2026

Mar 18, 2026

Curanex Achieves Key Preclinical Milestone with Favorable Toxicology Profile at Maximum Dose, Advancing Toward IND Submission - Yahoo Finance

Mar 18, 2026

Mar 15, 2026

Curanex adds two pharmaceutical veterans to advisory board By Investing.com - Investing.com Nigeria

Mar 15, 2026

Mar 13, 2026

Curanex adds two advisors to scientific board ahead of IND filing By Investing.com - Investing.com India

Mar 13, 2026

Mar 12, 2026

Curanex adds two advisors to scientific board ahead of IND filing - Investing.com Australia

Mar 12, 2026

Mar 12, 2026

Curanex Expands Scientific Advisory Board With Two Distinguished Researchers - Bitget

Mar 12, 2026

Mar 12, 2026

TB and COVID scientists join Curanex board to steer 2026 trial plans - Stock Titan

Mar 12, 2026

Mar 12, 2026

Curanex adds two pharmaceutical veterans to advisory board - Investing.com India

Mar 12, 2026

Mar 11, 2026

Curanex Appoints Two Veteran Industry Leaders to Scientific Advisory Board - marketscreener.com

Mar 11, 2026

Mar 11, 2026

Veteran drug creators with HIV, HCV medicines join Curanex - Stock Titan

Mar 11, 2026

Mar 06, 2026

Curanex Formalizes Long-Term Executive Employment and Compensation Agreements - TipRanks

Mar 06, 2026

Mar 06, 2026

Curanex Pharmaceuticals Inc Enters into Executive Employment Agreement with Jun Liu as President and Chairman of the Board, Effective March 1, 2026 - marketscreener.com

Mar 06, 2026

Mar 06, 2026

[8-K] Curanex Pharmaceuticals Inc Reports Material Event - Stock Titan

Mar 06, 2026

Mar 05, 2026

12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga

Mar 05, 2026

Mar 05, 2026

Curanex Forms World Class Scientific Advisory Board - Bitget

Mar 05, 2026

Feb 27, 2026

Curanex Pharmaceuticals Inc (CURX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Feb 27, 2026

Feb 27, 2026

Stocks in the News: ALBT, NDRA, CURX, HCTIAI, Clinical Milestones Drive Market Surges - marketscreener.com

Feb 27, 2026

Feb 26, 2026

Market Movers | Winners: IXHL, ALBT, RXT | Losers: THRY, EOSE, ERII - Trefis

Feb 26, 2026